UMPS and cholangiocarcinoma: It has recently been observed that cholangiocarcinoma patients with high expression of OPRT benefited from postoperative adjuvant chemotherapy with S-1 (an oral fluoropyrimidine, which is an OPRT inhibitor) [58].